Health Facility Assessment Indicators | (n = 10 Health Facilities) | |
Yes | No | |
Availability of malaria treatment drugs for first-line treatment in MIPs Uncomplicated or severe malaria in all trimesters |
| |
Artemether plus lumefantrine ALU (Coartem) | 8 (80%) | 2 (20%) |
Oral Quinine | 4 (40%) | 6 (60%) |
Parenteral Artesunate | 2 (20%) | 8 (80%) |
Availability of antimalarial drugs for second-line treatment in MIPs Uncomplicated or severe malaria in all trimesters |
| |
Oral Quinine | 4 (40%) | 6 (60%) |
Parenteral Quinine | 2 (20%) | 8 (80%) |
Availability antimalarial drugs (chemoprevention in pregnancy) |
|
|
Sulfadoxine/pyrimethamine (SP) fansidar tablet | 4 (40%) | 6 (60%) |
Availability malaria diagnostic tests (RDTs and microscopy) at the facility |
| |
Malaria diagnostic tests mRDT | 9 (90%) | 1 (10%) |
Microscopy | 2 (20%) | 8 (80%) |
Revised national malaria guidelines 2016 available at the health facility | 0 (0%) | 10 (100%) |
Malaria diagnostic tests mRDT uses wall charts available at the health facility | 0 (0%) | 10 (100%) |
Anti-malarial dosing wall charts or brochure available at health facility | 4 (40%) | 6 (60%) |
Clinical algorithm (flow chart)wall charts or brochure at health facility | 4 (40%) | 6 (60%) |
Malaria educational, teaching aides or materials e.g. information and education & communication IEC materials for malaria prevention in pregnancy displayed on wall charts | 4 (40%) | 6 (60%) |
LLINs/ITNs distributed/dispensed to pregnant women at ANC | 0 (0%) | 10 (100%) |
Health facility currently provide pre-referral treatment for severe malaria before transfer to the inpatient ward. | 3 (30%) | 7 (70%) |
Health facility had in place malaria cases recording and reporting system e.g. a record books, registers and Cards. | 10 (100%) | 0 (0%) |